Acinetobacter baumannii is a pathogen that causes hospital-acquired infections that are very difficult to treat, because they are resistant to most currently available antibiotics. As one of the World Health Organization’s three critical priority pathogens, new antibiotics for Acinetobacter baumannii are urgently needed, and is now one step closer to being tackled, as researchers from the Department of Chemistry — University of Warwick have made a breakthrough in understanding the enzymes that assemble the antibiotic enacyloxin.
To learn more, see original article at: https://www.sciencedaily.com/releases/2019/09/190924104057.htm
